Business Development
Partner with Gero to move discovery into the clinic.
We work with pharma teams, research groups, and investors who want to apply a physics-and-AI engine to real programs. Pick the model that fits and we will scope it with you.
20+years of deal experience
2open tools to build on
75+publications behind the science
1direct line to the team
Four ways to work together.
Each model has a clear scope and a clear owner on our side.
Model 01
Target discovery collaboration
Bring a disease area; we apply our model of aging dynamics to find and rank tractable targets, then design candidate molecules against them.
Model 02
Platform access
Use ProtoBind-Diff and Harvest on your own programs, with our team supporting setup, evaluation, and interpretation.
Model 03
Licensing
License methods and assets emerging from the program. Our team has initiated and closed numerous licensing and investment deals.
Model 04
Investment
Back the mission to end age-related disease. We work with investors who think in long horizons and hard science.
Start a conversation
Tell us what you're working on.
Share the program, the model you have in mind, and the timeline. We read every submission and reply directly.
Or email us
info@gero.ai